@article {320, title = {Pharmacy Research Policy and Procedures: New initiative Project in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {01-02}, type = {Editorial}, chapter = {01}, abstract = {

In recent years, the number of healthcare research studies with a focus on pharmaceutical care has increased in Arabic countries, emphasized in Saudi Arabia.[1-4] Furthermore, regulations and guidelines for conducting human scientific research have been developed in the healthcare system, as have types of research reporting or scientific publications.[5-17] The standards for conducting research place a greater emphasis on humanitarian, such as protecting human welfare, improving patient safety from any potential hazards, and improving clinical trial outcomes in healthcare systems. Therefore, patient protection was standardized, while the system also encouraged researchers to investigate healthcare services by categorizing research into different categories. The exempted ground is that; any study that does not harm patients, such as healthcare research, education surveys, native reviews, systemic reviews, and metaanalysis research, is exempted from the ethical committee{\textquoteright}s review and approval.[18,19].\  Read more....

}, keywords = {Nil}, doi = {10.5530/ijpcs.2022.11.1}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar} }